Burden of Noninfluenza Respiratory Virus Infection Considerable
MONDAY, March 29, 2021 -- For adults admitted to hospital, the burden of noninfluenza respiratory virus (NIRV) infection is considerable, and associated outcomes may be as severe as those seen with influenza, according to a study published online March 29 in CMAJ, the journal of the Canadian Medical Association.
Nelson Lee, M.D., from the University of Alberta in Edmonton, Canada, and colleagues analyzed pooled patient data from two hospital-based respiratory virus surveillance cohorts in two regions of Canada during the 2015/2016, 2016/2017, and 2017/2018 seasons. Data were included for 2,119 patients aged 18 years and older who were hospitalized for influenza-like illness or pneumonia.
Of the participants, 54.6 percent had NIRV infections, including 14.9, 12.9, and 8.2 percent with human rhinovirus/enterovirus, respiratory syncytial virus, and human coronavirus, respectively; 45.4 percent had influenza. The researchers found that patients with NIRVs were younger (mean age, 66.4 years) and more often had immunocompromising conditions (30.3 percent); these patients also more often had a delay in diagnosis (median 4.0 days). Of the NIRV infections, 14.6 percent were acquired in hospital. For patients with NIRV infection and those with influenza, admission to the intensive care unit, hospital length of stay, 30-day mortality, and the ordinal outcomes were similar. Worse outcomes were seen in association with age older than 60 years, being in an immunocompromised state, and having a hospital-acquired viral infection. Per acute care admission, the estimated median cost was $6,000.
"Our findings highlight unmet needs and research gaps in therapeutics and vaccines for people at high risk of NIRV infection," the authors write.
One author disclosed financial ties to the biopharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
FRIDAY, April 9, 2021 -- The world's first transplant of lung tissue from living donors to a COVID-19 patient with severe lung damage was announced Thursday by doctors in...
TUESDAY, April 6, 2021 -- Higher levels of physical activity and lower levels of exposure to air pollution are associated with a lower risk for type 2 diabetes, according to a...
FRIDAY, April 2, 2021 -- For patients with COVID-19 pneumonia, rates of mortality and 30-day readmission are low with discharge on home oxygen, according to a study published...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.